Combination checkpoint inhibitor therapy induces multiple immune major related adverse events in the treatment of vaginal melanoma: A cautionary case report

BACKGROUND: Immune checkpoint inhibitors (ICI) eliminate cancer cells through release of inhibition of cytotoxic CD8+ lymphocytes. Potent systemic activation of immune cells provides unprecedented efficacy in some types of advanced cancer therapy, but also often induces serious immune related advers...

Descripción completa

Detalles Bibliográficos
Autores principales: Norwood, T. Graham, Wang, Michelle J., Huh, Warner K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849148/
https://www.ncbi.nlm.nih.gov/pubmed/31737773
http://dx.doi.org/10.1016/j.gore.2019.100508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849148/
https://www.ncbi.nlm.nih.gov/pubmed/31737773
http://dx.doi.org/10.1016/j.gore.2019.100508

Ejemplares similares